HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

5-Aminolevulinic acid-mediated photodynamic activity in patient-derived cholangiocarcinoma organoids.

AbstractBACKGROUND:
Accurate diagnosis of the disease extension of cholangiocarcinoma (CCA) is often difficult in clinical practice. The diagnostic yield of conventional pre-operative imaging or endoscopic procedures is sometimes insufficient for the evaluation of longitudinal spreading of CCA. Here we investigated the usefulness of 5-aminolevulinic acid (5-ALA) for the pre- or intra-operative diagnosis of CCA, using patient-derived organoids.
METHODS:
Four CCA- and two adjacent tissue-derived organoids were established. After 5-ALA treatment, we assessed their photodynamic activity using fluorescence microscopy.
RESULTS:
CCA organoids established from different patients showed diverse morphology in contrast to monolayer structures of non-tumor organoids, and had the ability to form subcutaneous tumors in immunodeficient mice. CCA organoids demonstrated remarkably high photodynamic activity based on higher accumulation of protoporphyrin IX as a metabolite of 5-ALA compared to non-tumor organoids (40-71% vs. < 4%, respectively). Importantly, cancer cell-specific high photodynamic activity distinguished the organoids originated from biliary stenotic lesions from those of non-stenotic lesions in a CCA patient. The high photodynamic activity did not depend on the expression profile of heme biosynthesis genes.
CONCLUSIONS:
Distinct 5-ALA-based photodynamic activity could have diagnostic potential for the discrimination of CCA from non-tumor tissues.
AuthorsHiroaki Fujiwara, Naminatsu Takahara, Keisuke Tateishi, Mariko Tanaka, Sachiko Kanai, Hiroyuki Kato, Takuma Nakatsuka, Keisuke Yamamoto, Hirofumi Kogure, Junichi Arita, Yousuke Nakai, Masato Kasuga, Tetsuo Ushiku, Kiyoshi Hasegawa, Kazuhiko Koike
JournalSurgical oncology (Surg Oncol) Vol. 35 Pg. 484-490 (Dec 2020) ISSN: 1879-3320 [Electronic] Netherlands
PMID33126085 (Publication Type: Journal Article)
CopyrightCopyright © 2020 Elsevier Ltd. All rights reserved.
Chemical References
  • Levulinic Acids
  • Protoporphyrins
  • protoporphyrin IX
Topics
  • Aged
  • Aged, 80 and over
  • Animals
  • Bile Duct Neoplasms (drug therapy, metabolism, pathology)
  • Cholangiocarcinoma (drug therapy, metabolism, pathology)
  • Female
  • Follow-Up Studies
  • Humans
  • Levulinic Acids (pharmacology)
  • Male
  • Mice
  • Mice, Inbred NOD
  • Mice, SCID
  • Middle Aged
  • Organoids (drug effects, metabolism, pathology)
  • Photochemotherapy (methods)
  • Prognosis
  • Protoporphyrins (analysis, metabolism)
  • Xenograft Model Antitumor Assays
  • Aminolevulinic Acid

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: